Adding dexmedetomidine to pain block for heart surgery
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests adding a medicine called dexmedetomidine to a standard pain-blocking injection (ropivacaine) used during heart surgery. The goal is to see if it reduces pain and speeds recovery better than the injection alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 65 years old.
- You are scheduled for elective (non-emergency) heart bypass (CABG) or valve surgery, without any other heart or blood vessel procedures.
- Your heart's pumping strength (ejection fraction) is above 35%.
- You do not have kidney failure (creatinine level over 1.5) or liver failure.
- You have not had a heart attack in the last 7 days, and you do not need a balloon pump to help your heart.
- You have no infection at the block site, no allergy to local anesthetics, no psychiatric illness, and you are expected to be weaned from the ventilator soon after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a medication called dexmedetomidine to the standard numbing medicine (bupivacaine) in a pain block after lower abdominal cancer surgery can improve pain relief. It compares two different doses of the added medication to see which works better.
This study compares two medications (dexmedetomidine and fentanyl) mixed with a numbing agent to see which works better for blocking pain during above-knee amputation surgery in patients with serious heart or lung disease. Both drugs are already used in anesthesia, and this trial tests which combination is safest and most effective for you.
This trial tests whether adding a medication called dexmedetomidine to a numbing injection around shoulder nerves can improve pain control after laparoscopic shoulder surgery. The goal is to see if this combination works better than the numbing medication alone.
This study tests two ways to manage anesthesia during minimally invasive heart surgery: one uses a numbing injection near the spine plus a drug called dexmedetomidine, and the other uses traditional opioid painkillers. The goal is to see which approach helps you wake up faster and recover with fewer side effects.
This trial studies whether dexmedetomidine can reduce pain after elective shoulder arthroscopy surgery done under general anesthesia. If you’re eligible, it may help improve postoperative comfort and reduce the need for additional pain treatment.
This study tests whether adding a medicine called dexmedetomidine to a nerve block (an injection near the spine) can improve pain relief after kidney stone surgery. It is for people who are generally healthy and scheduled for a kidney stone procedure.
Hear when a new Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.